drugset / Trial / NCT03376594

Benjakul Extract and Loratadine for Treatment Allergic Rhinitis Patients

NCT03376594

Phase 2 Completed 60 enrolled Thammasat University
RandomizedParallel-groupDouble-blindTreatment

Summary

1. To compare the effectiveness of Benjakul extract capsules at 300 mg per day with Loratadine drug in the treatment of allergic rhinitis patients in small group (Clinical Trial Phase II). 2. To study the safety and side effects of Benjakul extract capsules 300 mg per day and Loratadine drug for allergic rhinitis patients.

Timeline

Start
2017-07-30
Primary completion
2018-02-01
Completion
2018-03-31

Drugs

EvaluationDrugModalityDoseRoute
Comparator Benjakul Extract Unknown 100 mg Oral
Comparator Loratadine Small molecule 10 mg Oral

Indications